Search

everythinglearnresearchcommunity

for

Search:↓

More hair loss leads to higher risk of psychosexual disorders, especially in women.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

Men can experience female pattern hair loss, needing different treatments.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Frequent use of hair straighteners can cause hair loss similar to scarring alopecia in young Turkish women.

Amla oil may help treat hair loss.

The modified hair loss classification is more detailed but less user-friendly.

Hair loss greatly affects quality of life, and dermatologists are crucial for proper diagnosis and treatment.

Targeting IL-17 could help treat pattern hair loss.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Hair loss improved after removing pituitary tumor.

Female pattern hair loss, common in women, can be treated with various methods like minoxidil, anti-androgen treatments, and light therapy, but early intervention and realistic expectations are crucial.

Manage hair loss from trauma with scalp expansion, advancement flaps, and hair transplantation.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hair loss severity relates to increased miniaturization in female pattern hair loss.

Aromatase gene variation may increase female hair loss risk.

Finasteride improves hair density and thickness in women with hair loss.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Hair loss in women may have causes other than hormones.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

AR/EDA2R gene linked to early-onset female hair loss, but 20p11 gene not involved.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Combining low-level light therapy and minoxidil 5% is more effective for female hair loss than using either treatment alone.

Finasteride shows promise for female hair loss, but more research needed.